Navigation Links
DQA1 SSP UniTray®

ProductsDQA1 SSP UniTray®
Company Dynal Biotech, LLC
Item DQA1 SSP UniTray®
Features 
  • Saves time and cost
  • Fewer kits to inventory and QC
  • Allele level typing results
  • Cost effective alternative for ambiguity resolution
  • Easy data analysis
Description Our Class II Direct to High Res SSP kits provide high resolution typing of the entire locus with a single tray. Locus specific typing on a single tray reduces QC and testing costs while saving time.
  • Straight from genomic DNA to high resolution results, no need for initial low resolution typing
  • Allele level typing with a single tray
  • Unique reaction pattern for most common alleles
  • Can resolve ambiguities seen with other typing techniques
  • Same procedure and thermal cycling conditions as all SSP UniTray products
  • Compatible with UniMatch Plus Software
  • Negative control included in all products
Info Dynal Biotech, LLC
Customer Service: (800) 558-4511
Web site: http://www.dynalbiotech.com

Related medicine products :

1. A Locus High Res SSP UniTray®
2. Cw High Res SSP UniTray®
3. B Locus High Res SSP UniTray®
4. DQB1 SSP UniTray®
5. DPB1 SSP UniTray®
...peed refrigerated centrifuge. Instant rotor exchan...comprehensive control using VIDEOset graphic softw...individual password protection of programs, 10 acc...owerful refrigeration 4C or less, imbalance detect...
GP8R is a powerful 3-liter large capacity centrifuge which is flexible and easy to use with refrigeration facility. Performs separations 50-100% faster than the rest, powerful, accommodating and conv
The Rotanta 460 family of centrifuges is an extraordinary line that meets a wide range of demands. They feature high capacity, versatility and performance. Their state-of-the-art technology and high
The Spinchron 15 centrifuge provides all the versatility and high capacity needed for today's full-service clinical lab needs. This refrigerated model has a speed up to 15,300 rpm with the ability to
Medicine Products:
(Date:12/3/2008)...cinated by their brains, the way they work, change...ation for the Advancement of Science (AAAS) recomm...t fascination to engage middle and high school stu...hey shouldn,t drink alcohol. , "Parents need ever...o drink alcohol, particularly during the holiday s...
(Date:12/3/2008)...Dec. 3 Medical device manufacturer...y with the new requirements of the,amended Europe... in March,2010, a newly released Nerac white pape...easing share in the growing $86 billion,market th....S. medical device,companies, profits," write Ner...
(Date:12/3/2008)...o new treatments for PTSD, researchers say , ...e with stress-related psychiatric conditions have ...ps govern memories, a new study suggests. , For...airs to two groups of patients, those with major d...rs, and a healthy control group. , The researc...
(Date:12/3/2008).... Results of a phase III, international randomize...e for treating advanced ovarian cancer that signif...aths compared to the previously established treatm...nial Meeting of the International Gynecologic Canc...or impact on many countries where the new standard...
Breaking Medicine News(10 mins):Health News:When 'just say no' isn't enough: Try science 2Health News:New Requirements of EU Medical Device Directive Need Immediate Action, Nerac Analysts Urge in Newly Published White Paper 2Health News:New Requirements of EU Medical Device Directive Need Immediate Action, Nerac Analysts Urge in Newly Published White Paper 3Health News:Memory Formation Different in Those With Stress-Related Psychiatric Disorders 2Health News:International study supports new standard of treatment for women with advanced ovarian cancer 2
...rom Norway looked at 4.7 lakh births between 1977 ...ased blood pressure which is dangerous to the baby...n born in August had the lowest risk of pre-eclamp...e National Institute of Public Health in Oslo say ...
...have stated that Men who suffer from constipation ...ive brain disease Parkinson's some have suggested ...ction of the gut long before it manifests itself e...e research, said: "It could help us more effective...
... the FDA issued a statement about the potential fo...drug, Accutane. And now, reports say that the 15-y...per was prescribed the drug. At this point, invest...les J. Bishop, was actually taking Accutane at the...
...tudy has found gardening is the best form of exerc... Dr Sara Fenn and colleagues at the University of ...,000 women, including more than 3,000 aged 50 year...gardened at least once a week showed higher bone d...
Other Medicine News:
(Date:12/1/2008)..., Dec. 1 TargeGen has announced th...rom a multi-center, US-based clinical,trial of TG...been scheduled at,the 2008 American Society of He...presentation are as follows:, Title: ...ailable, JAK2-Selective In...
(Date:12/1/2008)...study shows the Prox1 gene is a two-way switch tha...ls to be reprogrammed so that they lose their iden..., , MEMPHIS, Tenn., Dec. 1 /PRNewswire-USNe...arch Hospital have discovered that a certain diffe...tity that it requires the constant expression of a...
(Date:12/1/2008)...ence Call Scheduled for Tuesday, December 9 at 11:...- , , SOUTH SAN FRANCISCO, Calif., Dec. 1 ...s, Inc. (Nasdaq: SNSS ), a biopharmaceutical com...ion of new oncology therapeutics, today announced ...eloid leukemia (AML) will be presented during the ...
(Date:11/30/2008)...Dec. 1 Abnormalities in... in children with autism spectrum disorder by usin...dy presented today at the annual meeting of the Ra..., "Using MEG, we can record the tiny magnetic f...said Timothy Roberts, Ph.D., vice chair of researc...
Breaking Medicine Technology:Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3Brain Waves Show Sound Processing Abnormalities in Autistic Children 2Brain Waves Show Sound Processing Abnormalities in Autistic Children 3Coating improves electrical stimulation therapy used for Parkinsons depression chronic pain 4896 1Coating improves electrical stimulation therapy used for Parkinsons depression chronic pain 4896 2Biological clock genes control plant growth 4893 1Biological clock genes control plant growth 4893 2Old and new therapies combine to tackle atherosclerosis 7697 1Old and new therapies combine to tackle atherosclerosis 7697 2Old and new therapies combine to tackle atherosclerosis 7697 3Cequent Pharmaceuticals Meets Novartis Option Fund Milestone 3B Continues to Next Phase to Validate Inflammatory Bowel Disease Targets in Vivo 7694 1Cequent Pharmaceuticals Meets Novartis Option Fund Milestone 3B Continues to Next Phase to Validate Inflammatory Bowel Disease Targets in Vivo 7694 2
...y & Tolerability Profile,in Subjects with Type...5 /PRNewswire-FirstCall/ -- Phase III data,present... Diabetes,Association demonstrated that saxaglipti...in development by Bristol-Myers,Squibb Company (NY...on with metformin, exhibited a statistically signi...
...ety & Tolerability Profile,in Subjects with Ty...ne 25, 2007 /PRNewswire-FirstCall/ -- Phase III da...e American Diabetes,Association demonstrated that ...4 (DPP-4) in development by Bristol-Myers,Squibb C...rmin,exhibited a statistically significant improv...
Other Medicine Technology:Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 2Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 3Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 4Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 5Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 6Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 2Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 3Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 4Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 5Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 6